Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,294,081 papers from all fields of science
Search
Sign In
Create Free Account
glucolipsin-A
Known as:
glucolipsin A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Disaccharides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Total synthesis of oxacyclic macrodiolide natural products.
E. Kang
,
E. Lee
Chemical Reviews
2005
Corpus ID: 26061133
1. Intoduction 4348 2. Oxolane Macrodiolides 4348 2.1. Pamamycin 607 (1) 4348 2.1.1. Thomas Total Synthesis20 4349 2.1.2. Lee…
Expand
2004
2004
Structure assignment, total synthesis, and evaluation of the phosphatase modulating activity of glucolipsin A.
A. Fürstner
,
J. Ruiz-Caro
,
H. Prinz
,
H. Waldmann
Journal of Organic Chemistry
2004
Corpus ID: 36785530
The previously unknown stereostructure of glucolipsin A (1), a complex glycolipid endowed with glucokinase-activating properties…
Expand
2002
2002
A concise synthesis of the fully functional lactide core of cycloviracin B with implications for the structural assignment of related glycolipids.
A. Fürstner
,
M. Albert
,
J. Młynarski
,
M. Matheu
Journal of the American Chemical Society
2002
Corpus ID: 12492778
The absolute stereochemistry at the site of attachment of the fatty acid residues to the lactide core of the glycolipids…
Expand
1999
1999
Glucolipsin A and B, two new glucokinase activators produced by Streptomyces purpurogeniscleroticus and Nocardia vaccinii.
J. Qian-Cutrone
,
T. Ueki
,
+12 authors
S. Manly
Journal of antibiotics (Tokyo. )
1999
Corpus ID: 41021405
During the screening of the natural products for their ability to increase the activity of glucokinase by relieving inhibition by…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE